Article

Avedro, Inc., company update: Epi-on crosslinking (CXL) and PiXL technology

Author(s):

Julianne Mobilian
Conferences|ASCRS

ICYMI: Here's what's in the 2019 pipeline

Rajesh Rajpal, MD, Chief Medical Officer of Avedro, Inc., provides a company update on Epi-on crosslinking (CXL) and PiXL technology during the 2019 ASCRS conference in San Diego.

Related Videos
EyeCon 2024: Laura M. Periman, MD, shares her passion for dry eye disease, discussing her surprising discovery of the Alpenglow Sign in Demodex blepharitis
Fasika Woreta, MD, MPH, Eugene de Juan, M.D. Professor of Ophthalmic Education at Wilmer Eye Institute’s Baltimore and Columbia locations, discusses the NMA meeting
Cochair Kelly K. Nichols, OD, PhD, MPH, FAAO, highlights her passion for dry eye research and the vital collaboration between ophthalmology and optometry
Related Content
Recent changes to cornea: Preferred Practice Patterns
November 21st 2024

Recent changes to cornea: Preferred Practice Patterns

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Emmecell announces topline results from Phase 1 extension study of EO2002 for corneal edema
November 18th 2024

Emmecell announces topline results from Phase 1 extension study of EO2002 for corneal edema

Ehsan Sadri, MD, and Colin Green, PhD: How a noninvasive eye drop therapy could transform keratoconus care
September 23rd 2024

Innovation Series: What a noninvasive eye drop approach may mean for the future of keratoconus

Study: Deep learning models show promise in diagnosing infectious keratitis
October 28th 2024

Study: Deep learning models show promise in diagnosing infectious keratitis

First patient dosed in clinical trial to treat neuropathic corneal pain
October 23rd 2024

First patient dosed in clinical trial to treat neuropathic corneal pain

© 2024 MJH Life Sciences

All rights reserved.